Lupin partners with Takeda to launch novel gastrointestinal drug Vonoprazan in India
In a significant development, Lupin Limited, a global pharmaceutical leader, announced a non-exclusive patent licence agreement with Takeda Pharmaceutical Company Limited to commercialise Vonoprazan Tablets ... Read More
Torrent Pharmaceuticals licenses Vonoprazan from Takeda to treat GERD in India
Torrent Pharmaceuticals Limited has secured a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company Limited to commercialize Vonoprazan, a novel potassium-competitive acid blocker (P-CAB), in ... Read More